Edition:
United States

Biotechnology & Medical Research

Page 2

Human Metabolome Technologies to set up subsidiary

Thursday, 10 Dec 2015 01:00am EST

Human Metabolome Technologies Inc:To set up a Yokohama-based wholly owned subsidiary on Jan. 21, 2016.The new subsidiary with registered capital of 50 million yen to be engaged in production and sale of medical equipment for drug testing.

Alnylam Pharmaceuticals Inc and Collaborators Report First-Ever Evidence that Patisiran Reduces Pathogenic

Monday, 28 Sep 2015 08:00am EDT

Alnylam Pharmaceuticals Inc:Alnylam and collaborators report first-ever evidence that patisiran reduces pathogenic, misfolded transthyretin monomers.Patisiran achieves an approximately 90% reduction in misfolded non-native conformations of ttr as measured in serum.

Biocon Ltd lnaugurates world class devices facility & Introduces Basalog One

Tuesday, 15 Sep 2015 09:17am EDT

Biocon Ltd:Says inaugurated a world class facility for manufacturing new generaion patient-friendly devices for its insulines portfolio.

OncoTherapy Science starts TCR analysis business

Sunday, 6 Sep 2015 07:30pm EDT

OncoTherapy Science Inc:Started TCR (T Cell Receptor) analysis business.

Beijing Strong Biotechnologies establishes subsidiary

Tuesday, 1 Sep 2015 05:15am EDT

Beijing Strong Biotechnologies Inc:Invested 10 mln yuan and established a wholly owned medical diagnostic products subsidiary in Beijing.

Pharma Foods International to establish new subsidiary

Tuesday, 11 Aug 2015 08:00pm EDT

Pharma Foods International Co Ltd:To establish a new subsidiary located in Fukuoka in August.Says the new subsidiary will be engaged in call center business.Says the company will hold a 75 pct stake, an individual will hold a 20 pct stake and another company will hold a 5 pct stake respectively in the new subsidiary.New subsidiary to be capitalized at 10 million yen.

TSO3 announces formation of a unit

Monday, 6 Jul 2015 06:30am EDT

TSO3 Inc:Says formation of a wholly owned subsidiary: TSO3Corporation in the State of South Carolina, USA.Says new location is expected to open in August of this year in time to meet US customer requirements.

Guangzhou Boji Medical and Biotechnological to set up subsidiary

Friday, 3 Jul 2015 04:08am EDT

Guangzhou Boji Medical and Biotechnological Co Ltd:Says establishment of a wholly owned subsidiary in Lhasa, with a registered capital of 30 million yuan.The new subsidiary will be engaged in investment management.

Markets

  • Sectors
  • U.S.
  • Europe
  • Asia

Sector Summary